Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: higher MMP-9 levels are associated with plaque vulnerability

References

• Albuquerque LC, Narvaes LB, Maciel AA, et al. (2007). Intraplaque hemorrhage assessed by high-resolution magnetic resonance and C-reactive protein in carotid atherosclerosis. J Vasc Surg 46:1130–7
   PubMedGoogle Scholar
• Alvarez B, Ruiz C, Chacón P, et al. (2004). Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis. J Vasc Surg 40:469–75
   PubMedGoogle Scholar
• Barnett HJ, Taylor DW, Eliasziw M, et al. (1998). Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 339:1415–25
   PubMed Web of Science ®Google Scholar
• Blankenberg S, Rupprecht HJ, Poirier O, et al. (2003). AtheroGene Investigators: plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107:1579–85
   PubMed Web of Science ®Google Scholar
• Choudhary S, Higgins CL, Chen IY, et al. (2006). Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues. Arterioscler Thromb Vasc Biol 26:2351–8
   PubMed Web of Science ®Google Scholar
• De Nooijer R, Verkleij CJ, von der Thusen JH, et al. (2006). Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscl Thromb Vasc Biol 26:340–6
   PubMed Web of Science ®Google Scholar
• Devuyst G, Karapanayiotides T, Ruchat P, et al. (2005). Ultrasound measurement of the fibrous cap in symptomatic and asymptomatic atheromatous carotid plaques. Circulation 111:2776–82
   PubMedGoogle Scholar
• Ding S, Zhang M, Zhao Y, et al. (2008). The role of carotid plaque vulnerability and inflammation in the pathogenesis of acute ischemic stroke. Am J Med Sci 336:27–31
   PubMedGoogle Scholar
• Djurić T, Stojković L, Zivković M, et al. (2012). Matrix metalloproteinase-1 promoter genotypes and haplotypes are associated with carotid plaque presence. Clin Biochem 45:1353–6
   PubMed Web of Science ®Google Scholar
• Djurić T, Zivković M, Radak D, et al. (2008). Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis. Clin Biochem 41:1326–9
   PubMed Web of Science ®Google Scholar
• Dunleavey L, Beyzade S, Ye S. (2000a). Rapid genotype analysis of the matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk of cancer. Matrix Biol 19:175–7
   PubMedGoogle Scholar
• Dunleavey L, Beyzade S, Ye S. (2000b). Rapid genotype analysis of the stromelysin gene 5A/6A polymorphism. Atherosclerosis 151:587–9
   PubMed Web of Science ®Google Scholar
• Eldrup N, Gronholdt MM, Sillesen H, et al. (2006). Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis. Circulation 114:1847–54
   PubMed Web of Science ®Google Scholar
• Fiotti N, Moretti ME, Bussani R, et al. (2011). Features of vulnerable plaques and clinical outcome of UA/NSTEMI. Relationship with matrix metalloproteinase functional polymorphisms. Atherosclerosis 215:153–9
   PubMedGoogle Scholar
• Ghaderian SM, Akbarzadeh Najar R, Tabatabaei Panah AS. (2010). Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction. Coron Artery Dis 21:330–5
   PubMedGoogle Scholar
• Ghilardi G, Biondi ML, DeMonti M, et al. (2002). Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 33:2408–12
   PubMed Web of Science ®Google Scholar
• Goldstein LB, Adams R, Alberts MJ, et al. (2006). American Heart Association/American Stroke Association Stroke Council; Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; Quality of Care and Outcomes Research Interdisciplinary Working Group; and American Academy of Neurology: primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 37:1583–633
   PubMed Web of Science ®Google Scholar
• Heo SH, Cho CH, Kim HO, et al. (2011). Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. J Clin Neurol 7:69–76
   PubMedGoogle Scholar
• Ketelhuth DF, Bäck M. (2011). The role of matrix metalloproteinases in atherothrombosis. Curr Atheroscler Rep 13:162–9
   PubMed Web of Science ®Google Scholar
• Kunte H, Kunte G, Busch MA, et al. (2010). Differences in carotid plaque content of macrophages, T cells and MMP-9 between patients with embolic and hemodynamic cerebral ischemia due to symptomatic carotid stenosis. Atherosclerosis 211:456–60
   PubMedGoogle Scholar
• Lahiri DK, Nurnberger JI. (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Hansson GK. (2011). Progress and challenges in translating the biology of atherosclerosis. Nature 473:317–25
   PubMed Web of Science ®Google Scholar
• Lien LM, Hsieh YC, Bai CH, et al. (2010). Association of blood active matrix metalloproteinase-3 with carotid plaque score from a community population in Taiwan. Atherosclerosis 212:595–600
   PubMed Web of Science ®Google Scholar
• Loftus IM, Naylor AR, Goodall S, et al. (2000). Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 31:40–7
   PubMed Web of Science ®Google Scholar
• Moody AR, Murphy RE, Morgan PS, et al. (2003). Characterization of complicated carotid plaque with magnetic resonance: direct thrombus imaging in patients with cerebral ischemia. Circulation 107:3047–52
   PubMed Web of Science ®Google Scholar
• Nanni S, Melandri G, Hanemaaijer R, et al. (2007). Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms. Transl Res 149:137–44
   PubMedGoogle Scholar
• Nederkoorn PJ, van der Graaf Y, Hunink MG. (2003). Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: a systematic review. Stroke 34:1324–32
   PubMed Web of Science ®Google Scholar
• Pöllänen PJ, Karhunen PJ, Mikkelsson J, et al. (2001). Coronary artery complicated lesion area is related to functional polymorphisms of matrix metalloproteinase 9 gene: an autopsy study. Arterioscler Thromb Vasc Biol 21:1446–50
   PubMedGoogle Scholar
• Pöllänen PJ, Lehtimäki T, Mikkelsson J, et al. (2005). Matrix metalloproteinase 3 and 9 gene promoter polymorphisms: joint action of two loci as a risk factor for coronary artery complicated plaques. Atherosclerosis 180:73–8
   PubMedGoogle Scholar
• Rauramaa R, Vaisanen SB, Luong LA, et al. (2000). Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 20:2657–62
   PubMed Web of Science ®Google Scholar
• Vercelino R, Crespo I, de Souza GF, et al. (2010). S-nitroso-N-acetylcysteine attenuates liver fibrosis in cirrhotic rats. J Mol Med 88:401–11
   PubMedGoogle Scholar
• Zhang B, Ye S, Herrmann SM, et al. (1999). Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99:1788–94
   PubMed Web of Science ®Google Scholar